|
Hearken to this text  |
The Misso robotic will assist surgeons with personalised pre-planning and exact reducing for joint alternative. | Supply: Meril
Meril Life Sciences Pvt. Ltd. this week unveiled its Misso surgical robotic for simplifying orthopedic procedures.
The India-based firm introduced on LinkedIn that it’s creating surgical robotic for complete knee procedures. It stated it designed Misso to assist surgeons with personalised pre-planning and exact reducing for joint replacements.
Misso has an optical monitoring sensor, a six-axis articulated robotic arm, and “superior” security programs, claimed Meril. The surgical robotic may also help physicians carry out real-time hole checks and modify a surgical plan intraoperatively, it defined.
Numerous reducing choices can be found on the Misso, together with full and partial reducing based mostly on surgeon choice. Reducing guides usually are not required, and the system can carry out a tibial lower and a totally completed femur with all of the cuts, together with peg holes, in line with the firm.
Misso contains security options
Meril designed Misso with bone-movement monitoring to make sure security throughout procedures. If bone motion is noticed, the resection course of stops.
The resection will proceed with automated restoration of the bone place. If the robotic system’s instruments contact the affected person or different object, the collaborative robotic arm will instantly cease shifting.
Misso makes use of optical tracking-based navigation and robotic help to make sure correct leads to shaping and aligning synthetic knee joint parts. The corporate goals to enhance post-operative outcomes, cut back issues, and promote quicker affected person restoration.
Meril joins aggressive surgical robotic market
Based in 2006, Meril stated it’s devoted to the innovation, design, and improvement of novel, clinically related units. Its product portfolio contains vascular intervention units, orthopedic implants, robotics, endo-surgery, ENT merchandise, and in-vitro diagnostics.
The corporate has joined the rising surgical robotics market, the place it’s going to compete with orthopedic surgical robotic builders comparable to Stryker and Zimmer Biomet. Stryker launched its its Mako surgical robotic in 2017 and launched a joint-replacement providing in February 2024.
Additionally in February, the U.S. Meals and Drug Administration (FDA) cleared Zimmer Biomet’s Rosa surgical robotic platform for shoulder and hip alternative procedures. The FDA had cleared it for partial knee alternative for partial knee alternative in April 2021.
Editor’s notice: This text is syndicated from The Robotic Report sibling website MassDevice.